The Discounted Cash Flow (DCF) valuation of Clinuvel Pharmaceuticals Ltd (CUV.AX) is 11.45 AUD. With the latest stock price at 9.99 AUD, the upside of Clinuvel Pharmaceuticals Ltd based on DCF is 14.6%.
Based on the latest price of 9.99 AUD and our DCF valuation, Clinuvel Pharmaceuticals Ltd (CUV.AX) is a buy. buying CUV.AX stocks now will result in a potential gain of 14.6%.
| Range | Selected | |
| WACC / Discount Rate | 9.7% - 12.5% | 11.1% |
| Long-term Growth Rate | 1.0% - 3.0% | 2.0% |
| Fair Price | 9.37 - 14.99 | 11.45 |
| Upside | -6.2% - 50.1% | 14.6% |